The application of adipose tissue-derived stromal cells (ASCs) in regenerative medicine has become a growing trend due to its abundance and differentiation potentials. However, several breast cancer studies indicated that ASCs promote tumor progression, therefore, the use of ASCs for reconstruction after oncological surgery poses potential risks. | Differential response of non-cancerous and malignant breast cancer cells to conditioned medium of adipose tissue-derived stromal cells (ASCs)
